BOSTON OMAHA CORP-CL A (BOC) Fundamental Analysis & Valuation

NYSE:BOC • US1010441053

Current stock price

12.2 USD
0 (0%)
At close:
12.2 USD
0 (0%)
After Hours:

This BOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BOC Profitability Analysis

1.1 Basic Checks

  • In the past year BOC has reported negative net income.
  • BOC had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BOC reported negative net income in multiple years.
  • Of the past 5 years BOC 4 years had a positive operating cash flow.
BOC Yearly Net Income VS EBIT VS OCF VS FCFBOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

  • BOC has a Return On Assets of -1.74%. This is comparable to the rest of the industry: BOC outperforms 55.56% of its industry peers.
  • Looking at the Return On Equity, with a value of -2.41%, BOC is in the better half of the industry, outperforming 65.56% of the companies in the same industry.
Industry RankSector Rank
ROA -1.74%
ROE -2.41%
ROIC N/A
ROA(3y)-0.94%
ROA(5y)0.95%
ROE(3y)-1.32%
ROE(5y)1.62%
ROIC(3y)N/A
ROIC(5y)N/A
BOC Yearly ROA, ROE, ROICBOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • BOC has a better Gross Margin (65.84%) than 82.22% of its industry peers.
  • BOC's Gross Margin has improved in the last couple of years.
  • BOC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.65%
GM growth 5Y2.04%
BOC Yearly Profit, Operating, Gross MarginsBOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BOC Health Analysis

2.1 Basic Checks

  • BOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BOC has less shares outstanding than it did 1 year ago.
  • BOC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BOC has a worse debt to assets ratio.
BOC Yearly Shares OutstandingBOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BOC Yearly Total Debt VS Total AssetsBOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • BOC has an Altman-Z score of 1.35. This is a bad value and indicates that BOC is not financially healthy and even has some risk of bankruptcy.
  • BOC has a Altman-Z score of 1.35. This is in the better half of the industry: BOC outperforms 63.33% of its industry peers.
  • BOC has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.09, BOC is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACCN/A
WACC8.65%
BOC Yearly LT Debt VS Equity VS FCFBOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.98 indicates that BOC should not have too much problems paying its short term obligations.
  • BOC's Current ratio of 1.98 is fine compared to the rest of the industry. BOC outperforms 72.22% of its industry peers.
  • A Quick Ratio of 1.98 indicates that BOC should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.98, BOC is in the better half of the industry, outperforming 74.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.98
BOC Yearly Current Assets VS Current LiabilitesBOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BOC Growth Analysis

3.1 Past

  • BOC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -900.00%.
  • The Revenue has been growing slightly by 5.34% in the past year.
  • Measured over the past years, BOC shows a very strong growth in Revenue. The Revenue has been growing by 20.12% on average per year.
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-235.29%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y12.08%
Revenue growth 5Y20.12%
Sales Q2Q%-4.39%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y79.8%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.04%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BOC Yearly Revenue VS EstimatesBOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BOC Yearly EPS VS EstimatesBOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. BOC Valuation Analysis

4.1 Price/Earnings Ratio

  • BOC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BOC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BOC Price Earnings VS Forward Price EarningsBOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BOC.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.97
BOC Per share dataBOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BOC Dividend Analysis

5.1 Amount

  • BOC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BOC Fundamentals: All Metrics, Ratios and Statistics

BOSTON OMAHA CORP-CL A

NYSE:BOC (4/16/2026, 6:09:48 PM)

After market: 12.2 0 (0%)

12.2

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-30
Earnings (Next)05-12
Inst Owners66.57%
Inst Owner Change0%
Ins Owners4.09%
Ins Owner Change0.82%
Market Cap374.17M
Revenue(TTM)114.38M
Net Income(TTM)-12.43M
Analysts45
Price Target14.28 (17.05%)
Short Float %5.48%
Short Ratio11.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-437.95%
Min EPS beat(2)-659.08%
Max EPS beat(2)-216.83%
EPS beat(4)0
Avg EPS beat(4)-376.24%
Min EPS beat(4)-659.08%
Max EPS beat(4)-216.83%
EPS beat(8)1
Avg EPS beat(8)-149.32%
EPS beat(12)2
Avg EPS beat(12)-114.34%
EPS beat(16)3
Avg EPS beat(16)-318.22%
Revenue beat(2)0
Avg Revenue beat(2)-5.1%
Min Revenue beat(2)-8.82%
Max Revenue beat(2)-1.39%
Revenue beat(4)1
Avg Revenue beat(4)-3.48%
Min Revenue beat(4)-8.82%
Max Revenue beat(4)1.31%
Revenue beat(8)4
Avg Revenue beat(8)-1.44%
Revenue beat(12)6
Avg Revenue beat(12)-0.62%
Revenue beat(16)8
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.27
P/FCF N/A
P/OCF 20.95
P/B 0.72
P/tB 1.32
EV/EBITDA 13.97
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)0.58
OCFY4.77%
SpS3.73
BVpS16.83
TBVpS9.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.74%
ROE -2.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.84%
FCFM N/A
ROA(3y)-0.94%
ROA(5y)0.95%
ROE(3y)-1.32%
ROE(5y)1.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.65%
GM growth 5Y2.04%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA 2.29
Cap/Depr 112.62%
Cap/Sales 24.39%
Interest Coverage N/A
Cash Conversion 85.82%
Profit Quality N/A
Current Ratio 1.98
Quick Ratio 1.98
Altman-Z 1.35
F-Score4
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)174.3%
Cap/Depr(5y)198.53%
Cap/Sales(3y)36.01%
Cap/Sales(5y)38.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-235.29%
EPS Next Y79.8%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.34%
Revenue growth 3Y12.08%
Revenue growth 5Y20.12%
Sales Q2Q%-4.39%
Revenue Next Year4.04%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year794.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.93%
OCF growth 3YN/A
OCF growth 5Y28.13%

BOSTON OMAHA CORP-CL A / BOC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BOSTON OMAHA CORP-CL A (BOC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BOC.


What is the valuation status for BOC stock?

ChartMill assigns a valuation rating of 0 / 10 to BOSTON OMAHA CORP-CL A (BOC). This can be considered as Overvalued.


How profitable is BOSTON OMAHA CORP-CL A (BOC) stock?

BOSTON OMAHA CORP-CL A (BOC) has a profitability rating of 3 / 10.